NASDAQ$ESTA

Establishment Labs Holdings Inc · Q4 2023 earnings

Q4 2023 earnings · · Investor relations

Briefing

Establishment Labs reported fourth quarter 2023 financial results and provided 2024 guidance.

Establishment Labs' fourth quarter revenue was $31.6 million, consistent with preannouncement. The company is focused on expense reduction, balance sheet security, and achieving positive adjusted EBITDA later this year and becoming cash flow positive in 2025.

  • Fourth quarter revenue of $31.6 million, consistent with preannouncement on January 9.
  • Fourth quarter net loss from operations of $22.1 million compared to a net loss of $13.2 million in the year-ago period.
  • Proforma cash balance of $90 million after $50 million private placement on January 9.
  • Launched Motiva Implants® in China.

Headline financials

Total Revenue

$31.6M

Previous: $43.8M-28.0%
EPS (adj)

-$0.79

Previous: -$0.55-43.6%
Gross Margin

65.2%

No prior period
Capital Expenditures

$655K

Previous: $966K-32.2%
Net Income

-$20.5M

Previous: -$13.6M-51.5%
Operating Income

-$22.1M

Previous: -$13.2M-68.0%
Gross Profit

$20.6M

Previous: $28.2M-26.9%
R&D Expense

$5.82M

No prior period
Stock-Based Comp

$3.45M

Previous: $3.26M+5.9%

Revenue & EPS history

Establishment Labs · Revenue · Quarterly

$31.6M

Q4 2023-28%vs Q4 2022
Beat estimate in 13 of 15 quarters(87%)
ActualEstimate

Forward guidance

The company provided 2024 revenue guidance of $174 million to $184 million, an increase of 5% to 11% over 2023. Guidance does not include revenue from Motiva Implants® in the United States, which is expected in 2024.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2023

Historical avgQ4 2023

+1.5%

Avg return

Earnings day

+0.7%

Avg return

5 days after

+2.4%

Avg return

30 days after

56%

18 / 32 earnings

Positive

+22.5%

Q3 2025

Best reaction

-26.0%

Q3 2023

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-0.4%-4.3%+2.9%
Q4 2025-1.9%+5.0%-20.1%
Q3 2025+22.5%+37.0%+43.2%
Q1 2025+4.9%+5.1%+14.2%
Q4 2024+17.9%+28.1%+12.1%
Q3 2024-5.2%-13.2%-10.0%
Q2 2024+3.4%+20.6%+23.5%
Q1 2024+5.4%+4.2%-10.8%
Q4 2023+15.1%+19.6%+28.2%
Q3 2023-26.0%-36.1%-31.7%
Q2 2023-8.4%-12.0%-12.2%
Q1 2023+1.8%-1.6%-1.9%
Q4 2022+7.2%+10.3%+0.3%
Q3 2022-7.7%+11.1%+27.1%
Q2 2022-3.0%+1.3%-0.4%
Q1 2022-10.5%-10.1%+2.3%
Q4 2021+3.3%+1.6%+11.5%
Q3 2021-10.6%-14.3%-15.2%
Q2 2021+6.0%-3.7%-3.1%
Q1 2021-0.6%-1.8%+8.9%
Q4 2020+0.4%-6.8%+9.5%
Q3 2020+8.9%-0.4%+22.6%
Q2 2020+6.2%+7.3%+9.3%
Q1 2020+2.9%+0.5%+15.3%
Q4 2019+4.5%-16.4%+0.4%
Q3 2019-0.3%+0.5%+7.8%
Q2 2019-5.2%-10.6%-10.2%
Q1 2019+1.5%-0.3%-15.9%
Q4 2018-1.9%-4.9%-15.2%
Q3 2017+10.3%+4.5%-6.2%
Q3 2018+10.3%+4.5%-6.2%
Q2 2018-2.7%-2.9%-3.4%
Q4 2017
Q2 2017
Q1 2017

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro